233 related articles for article (PubMed ID: 12237249)
1. A new ligand for the urotensin II receptor.
Camarda V; Guerrini R; Kostenis E; Rizzi A; Calò G; Hattenberger A; Zucchini M; Salvadori S; Regoli D
Br J Pharmacol; 2002 Oct; 137(3):311-4. PubMed ID: 12237249
[TBL] [Abstract][Full Text] [Related]
2. Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors.
Camarda V; Song W; Marzola E; Spagnol M; Guerrini R; Salvadori S; Regoli D; Thompson JP; Rowbotham DJ; Behm DJ; Douglas SA; Calo' G; Lambert DG
Eur J Pharmacol; 2004 Sep; 498(1-3):83-6. PubMed ID: 15363979
[TBL] [Abstract][Full Text] [Related]
3. Differential agonistic and antagonistic effects of the urotensin-II ligand SB-710411 at rodent and primate UT receptors.
Behm DJ; Herold CL; Camarda V; Aiyar NV; Douglas SA
Eur J Pharmacol; 2004 May; 492(2-3):113-6. PubMed ID: 15178353
[TBL] [Abstract][Full Text] [Related]
4. The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems.
Behm DJ; Stankus G; Doe CP; Willette RN; Sarau HM; Foley JJ; Schmidt DB; Nuthulaganti P; Fornwald JA; Ames RS; Lambert DG; Calo' G; Camarda V; Aiyar NV; Douglas SA
Br J Pharmacol; 2006 May; 148(2):173-90. PubMed ID: 16547525
[TBL] [Abstract][Full Text] [Related]
5. Urotensin-II receptor ligands. From agonist to antagonist activity.
Grieco P; Carotenuto A; Campiglia P; Marinelli L; Lama T; Patacchini R; Santicioli P; Maggi CA; Rovero P; Novellino E
J Med Chem; 2005 Nov; 48(23):7290-7. PubMed ID: 16279788
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor.
Batuwangala M; Camarda V; McDonald J; Marzola E; Lambert DG; Ng LL; Calo' G; Regoli D; Trapella C; Guerrini R; Salvadori S
Peptides; 2009 Jun; 30(6):1130-6. PubMed ID: 19463746
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11).
Marzola E; Camarda V; Batuwangala M; Lambert DG; Calo' G; Guerrini R; Trapella C; Regoli D; Tomatis R; Salvadori S
Peptides; 2008 May; 29(5):674-9. PubMed ID: 17822806
[TBL] [Abstract][Full Text] [Related]
8. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14.
Ames RS; Sarau HM; Chambers JK; Willette RN; Aiyar NV; Romanic AM; Louden CS; Foley JJ; Sauermelch CF; Coatney RW; Ao Z; Disa J; Holmes SD; Stadel JM; Martin JD; Liu WS; Glover GI; Wilson S; McNulty DE; Ellis CE; Elshourbagy NA; Shabon U; Trill JJ; Hay DW; Ohlstein EH; Bergsma DJ; Douglas SA
Nature; 1999 Sep; 401(6750):282-6. PubMed ID: 10499587
[TBL] [Abstract][Full Text] [Related]
9. Ligand-supported purification of the urotensin-II receptor.
Du AT; Onan D; Dinh DT; Lew MJ; Ziogas J; Aguilar MI; Pattenden LK; Thomas WG
Mol Pharmacol; 2010 Oct; 78(4):639-47. PubMed ID: 20647393
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship study on human urotensin II.
Guerrini R; Camarda V; Marzola E; Arduin M; Calo G; Spagnol M; Rizzi A; Salvadori S; Regoli D
J Pept Sci; 2005 Feb; 11(2):85-90. PubMed ID: 15635628
[TBL] [Abstract][Full Text] [Related]
11. The neuromedin B receptor antagonist, BIM-23127, is a potent antagonist at human and rat urotensin-II receptors.
Herold CL; Behm DJ; Buckley PT; Foley JJ; Wixted WE; Sarau HM; Douglas SA
Br J Pharmacol; 2003 May; 139(2):203-7. PubMed ID: 12770925
[TBL] [Abstract][Full Text] [Related]
12. Functional and binding characterizations of urotensin II-related peptides in human and rat urotensin II-receptor assay.
Brkovic A; Hattenberger A; Kostenis E; Klabunde T; Flohr S; Kurz M; Bourgault S; Fournier A
J Pharmacol Exp Ther; 2003 Sep; 306(3):1200-9. PubMed ID: 12807997
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of SB-710411 (Cpa-c[D-Cys-Pal-D-Trp-Lys-Val-Cys]-Cpa-amide), a novel peptidic urotensin-II receptor antagonist.
Behm DJ; Herold CL; Ohlstein EH; Knight SD; Dhanak D; Douglas SA
Br J Pharmacol; 2002 Oct; 137(4):449-58. PubMed ID: 12359626
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of putative peptidic urotensin-II receptor antagonists on urotensin-II-induced contraction of cat isolated respiratory smooth muscle.
Behm DJ; Ao Z; Camarda V; Aiyar NV; Johns DG; Douglas SA
Eur J Pharmacol; 2005 Jun; 516(3):276-81. PubMed ID: 15975570
[TBL] [Abstract][Full Text] [Related]
15. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14.
Liu Q; Pong SS; Zeng Z; Zhang Q; Howard AD; Williams DL; Davidoff M; Wang R; Austin CP; McDonald TP; Bai C; George SR; Evans JF; Caskey CT
Biochem Biophys Res Commun; 1999 Dec; 266(1):174-8. PubMed ID: 10581185
[TBL] [Abstract][Full Text] [Related]
16. Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity.
Song W; McDonald J; Camarda V; Calo G; Guerrini R; Marzola E; Thompson JP; Rowbotham DJ; Lambert DG
Naunyn Schmiedebergs Arch Pharmacol; 2006 May; 373(2):148-57. PubMed ID: 16596397
[TBL] [Abstract][Full Text] [Related]
17. Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice.
Behm DJ; Harrison SM; Ao Z; Maniscalco K; Pickering SJ; Grau EV; Woods TN; Coatney RW; Doe CP; Willette RN; Johns DG; Douglas SA
Br J Pharmacol; 2003 May; 139(2):464-72. PubMed ID: 12770952
[TBL] [Abstract][Full Text] [Related]
18. Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375.
Douglas SA; Behm DJ; Aiyar NV; Naselsky D; Disa J; Brooks DP; Ohlstein EH; Gleason JG; Sarau HM; Foley JJ; Buckley PT; Schmidt DB; Wixted WE; Widdowson K; Riley G; Jin J; Gallagher TF; Schmidt SJ; Ridgers L; Christmann LT; Keenan RM; Knight SD; Dhanak D
Br J Pharmacol; 2005 Jul; 145(5):620-35. PubMed ID: 15852036
[TBL] [Abstract][Full Text] [Related]
19. Urantide: an ultrapotent urotensin II antagonist peptide in the rat aorta.
Patacchini R; Santicioli P; Giuliani S; Grieco P; Novellino E; Rovero P; Maggi CA
Br J Pharmacol; 2003 Dec; 140(7):1155-8. PubMed ID: 14645137
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist.
Chatenet D; Dubessy C; Boularan C; Scalbert E; Pfeiffer B; Renard P; Lihrmann I; Pacaud P; Tonon MC; Vaudry H; Leprince J
J Med Chem; 2006 Nov; 49(24):7234-8. PubMed ID: 17125276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
